AmplifyBio

Accelerate CNS Drug Delivery with AmplifyBio! At AmplifyBio, we specialize in preclinical studies tailored for central nervous system (CNS) therapies. Our dose route capabilities ensure precise and effective delivery to target sites within the brain and spinal cord. Among our specialized dose routes for CNS delivery are Intracerebroventricular, Intrathecal, Intratumoral, Intrathalamic, Intracisterna magna, Intracranial, and Inhalation. AmplifyBio accelerates your drug development with precision and care, no matter the dose route. At the upcoming SOT conference, our study direction team will present on the challenges and triumphs of dose administration on Tuesday, March 18th, 4:30 pm – 5:35 pm. ?? Learn more: https://bit.ly/3FnGbQM #CNSDrugDelivery #PreclinicalResearch #GeneTherapy #DrugDevelopment #AmplifyBio

Today, we celebrate women's intellectual curiosity and the equity of opportunities contributing to scientific discovery for generations. May we all continue to save seats at benches and board tables for all our brightest minds. “Nothing in life is to be feared. It is only to be understood. Now is the time to understand more, so that we may fear less." — Marie Curie

CRO, CDMO, CRDMO, PDMO—what do they all mean? As advanced therapy development has matured, these terms have become less easily defined. At AmplifyBio, we focus on what truly matters—delivering an integrated drug development experience. From characterization and R&D to preclinical safety and CMC, we seamlessly connect every stage from day one. Read the full blog to learn more. https://bit.ly/4hbrptl #AmplifyBio #CellAndGeneTherapy #DrugDevelopment #CRO #CDMO #CRDMO #PDMO #PreclinicalCRO

Heading to SOT 2025? Stop by booth #1321 to talk about inhalation toxicology AmplifyBio’s inhalation capabilities deliver precise, reliable data to advance therapies safely and efficiently. From preclinical models to dose delivery insights, we help you navigate the path to IND with confidence. Explore our inhalation services: AmplifyBio Inhalation Toxicology https://bit.ly/43hdqPz Connect with us at the SOT conference — let’s shape the future of inhalation studies together! #SOT2025 #InhalationToxicology #PreclinicalResearch #DrugDevelopment

Go Beyond Standard Studies with AmplifyBio’s Expert Pathology Support? At AmplifyBio, we understand that standard assessments don’t always reveal the full picture. Our expert, organ-specific guided recommendations are designed to help clients streamline studies and mitigate the risk of false findings through advanced staining, digital image analysis, and expert pathology insights. Why Partner with AmplifyBio? *?Expert Guidance: ACVP board-certified pathologists help you navigate complex organ assessments. *?Precision & Accuracy: Advanced techniques catch subtle pathology missed in routine studies. *?Data Integrity: Reduce the risk of artifacts and false positives with enhanced confirmation methods. *?Customizable Insights: Tailor panels to dig deeper into your organ of interest. Download the brochure to learn more https://bit.ly/435XgZc #PreclinicalResearch #Pathology #DrugDevelopment #Biotech #AmplifyBio #SafetyAssessment #CRO #LifeSciences #AmplifyBio #Pathology #PreclinicalCRO

AmplifyBio is excited to exhibit at the Society of Toxicology's 64th Annual Meeting and ToxExpo, March 16th - 20th, at the Orange County Convention Center in Orlando, Florida. Visit us at booth #1321 to meet the team and discover how we can advance your studies. Request a meeting: https://bit.ly/4gV092m #SOT25 #Toxicology #AmplifyBio #PreclinicalCRO

At AmplifyBio, World Cancer Day serves as a reminder of our mission: to advance groundbreaking therapies. Today, we unite with global efforts to raise awareness, inspire action, and drive progress against this formidable disease. Together, we're pioneering innovative solutions to improve patient outcomes and empower hope in the fight against cancer. #AmplifyBio #WorldCancerDay #cellandgenetherapies #curecancer #advancedtherapies

"We always want to be where these critical conversations are happening so we can be more effective partners and ultimately improve patient outcomes." - J. Kelly Ganjei, CEO AmplifyBio From streamlining preclinical development to tackling CMC challenges, our experts want to be part of the groups working on solutions for the commercialization of Advanced Therapies. This year AmplifyBio drove conversations on the future of CAR-T, GMP facility readiness, and the benefits of Hoteling and Hybrid staffing models for manufacturing services. https://lnkd.in/e9ugD-FV #cgt #atw25 #advancedtherapies #plasmid #cdmo #preclinicalcro #mrna #amplifybio

AmplifyBio recently partnered with OSU’s Biomedical Engineering Society to support students' career growth! From resume reviews with Study Director Brandon Lewis to representing AmplifyBio at the Engineering in Healthcare Symposium, our team shared insights and connected with future leaders in cell and gene therapy. Excited to inspire the next generation of innovators! #AmplifyBio #OSU #Innovation #biomedicalengineering #cellandgenetherapy #advandedtherapies

Kelly Ganjei, CEO of AmplifyBio, chaired a session alongside Dr. Bruce Levine from UPenn, delving into the advancements and future directions of Car T therapy. The panel addressed critical topics such as long-term patient tracking for regulatory compliance, cost control, and ensuring product accessibility without compromising quality. #AmplifyBio #ATW2025 #TCellTherapy #TCR #Biotech #Pharma #Innovation #CGT #CellTherapy #GeneTherapy